Table I.
Treatment | Group
|
||||
---|---|---|---|---|---|
D | XP0.1 | XP0.5 | XP1 | N | |
Der p 2 (75 μg/mla) 24 h | + | + | + | + | - |
XQLT pulse 1 h | - | 0.1 mg/ml | 0.5 mg/ml | 1 mg/ml | - |
Dose that maximizes nerve growth factor (NGF) production, determined in pre-titration trial. D, positive control; N, negative control; XQLT pulse 1 h, cells were treated with XQLT for 1 h, prior to the XQLT being washed out.